Skip to main content
logo
The Oncology Institute, Inc. (TOI)
NASDAQ: TOI · Real-Time Price · USD
3.480
-0.060 (-1.69%)
Apr 20, 2026, 11:17 AM EDT - Market open

The Oncology Institute Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
34435223151121874
Market Cap Growth
164.82%1403.89%-84.53%25.12%-86.16%834.75%
Enterprise Value
420.08414.9290.09181.71149.76758.43
Last Close Price
3.483.560.312.041.659.75
PE Ratio
--6.59-0.44-2.22-7.86-60.94
PS Ratio
0.700.700.060.470.484.30
PB Ratio
--22.396.522.650.988.39
P/TBV Ratio
-20.43-20.926.462.641.086.20
P/FCF Ratio
--12.67-0.77-3.70-1.80-24.59
P/OCF Ratio
--14.31-0.88-4.17-1.96-26.73
EV/Sales Ratio
0.840.830.230.560.593.74
EV/EBITDA Ratio
--14.24-1.67-2.55-1.93-17.84
EV/EBIT Ratio
--11.50-1.50-2.36-1.83-16.54
EV/FCF Ratio
--14.93-2.97-4.44-2.23-21.35
Debt / Equity Ratio
-6.14-6.1432.421.990.830
Debt / EBITDA Ratio
-3.56-3.56-2.29-1.68-1.390.00
Debt / FCF Ratio
-3.73-3.73-4.06-2.93-1.610.00
Net Debt / Equity Ratio
-4.46-4.4620.480.650.28-1.10
Net Debt / EBITDA Ratio
-2.41-2.41-1.36-0.52-0.442.71
Net Debt / FCF Ratio
-2.52-2.52-2.42-0.90-0.513.24
Asset Turnover
2.982.982.061.381.091.51
Inventory Turnover
31.7131.6828.6223.0825.5330.05
Quick Ratio
1.311.311.883.623.844.58
Current Ratio
1.591.592.154.124.395.17
Return on Equity (ROE)
999.19%999.19%-213.36%-92.20%0.13%-16.52%
Return on Assets (ROA)
-21.39%-21.44%-31.48%-32.72%58.86%-36.05%
Return on Invested Capital (ROIC)
-49.80%-49.91%-68.47%-58.91%123.16%-102.02%
Return on Capital Employed (ROCE)
-33.69%-33.69%-40.76%-37.90%-40.41%-43.52%
Earnings Yield
-14.38%-15.17%-229.77%-45.10%-12.73%-1.64%
FCF Yield
-7.94%-7.90%-129.59%-27.03%-55.66%-4.07%
Buyback Yield / Dilution
-23.11%-23.11%-1.76%8.51%-21.70%-12.03%
Total Shareholder Return
-23.11%-23.11%-1.76%8.51%-21.70%-12.03%
Updated Mar 12, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q